Post-approval studies (Phase 4)Study completedNCT01105481
What this trial is testing
Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients
Who this might be right for
Treatment-resistant Schizophrenia
National Health Research Institutes, Taiwan 273